Literature DB >> 34325727

Disparities in the change of cervical cancer mortality rate between urban and rural Chiang Mai in the era of universal health care and the Thai national screening program.

Patumrat Sripan1,2, Imjai Chitapanarux3,4,5, Ekkasit Tharavichitkul2,6, Pooriwat Muangwong2,6, Donsuk Pongnikorn7, Narate Waisri8, Chirapong Hanpragopsuk8, Puttachart Maneesai8, Panrada Tansiri8, Malisa Poungsombat8, Varunee Khamsan8.   

Abstract

BACKGROUND: The Ministry of Public Health of Thailand established universal health coverage (UHC) in 2002, which also included national-level screening for cervical cancer in 2005. This study examined the changes in mortality of cervical cancer in rural and urban areas in Chiang Mai Province of northern Thailand during the era of UHC and the immediately preceding period.
METHODS: Data of cervical cancer patients in Chiang Mai in northern Thailand, who died from 1998 through 2012, were used to calculate the change in age-standardized rates of mortality (ASMR) using a joinpoint regression model and to calculate estimated annual percent changes (APC). The change in mortality rate by age groups along with changes by geographic area of residence were determined.
RESULTS: Among the 1177 patients who died from cervical cancer, 13(1%), 713 (61%) and 451 (38%) were in the young age group (aged < 30), the screening target group (aged 30-59) and the elderly group (aged ≥60), respectively. The mortality rate among women aged 30-59 significantly declined by 3% per year from 2003 through 2012 (p < 0.001). By area of residence, the mortality rate in women targeted by the screening program significantly decreased in urban areas but remained stable in more rural areas, APC of - 7.6 (95% CI: - 12.1 to - 2.8) and APC of 3.7 (95% CI: - 2.1 to 9.9), respectively.
CONCLUSION: The UHC and national cervical cancer screening program in Thai women may have contributed to the reduction of the mortality rate of cervical cancer in the screening target age group. However, this reduction was primarily in urban areas of Chiang Mai, and there was no significant impact on mortality in more rural areas. These results suggest that the reasons for this disparity need to be further explored to equitably increase access to cervical cancer services of the UHC.
© 2021. The Author(s).

Entities:  

Keywords:  Area of residence; Cervical cancer; Disparity; Mortality trend; Screening

Year:  2021        PMID: 34325727     DOI: 10.1186/s12939-021-01515-1

Source DB:  PubMed          Journal:  Int J Equity Health        ISSN: 1475-9276


  19 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

2.  Impact of universal health care and screening on incidence and survival of Thai women with cervical cancer: A population-based study of the Chiang Mai Province.

Authors:  Patumrat Sripan; Imjai Chitapanarux; Miranda M Fidler-Benaoudia; Adalberto Miranda-Filho; Aude Bardot; Donsuk Pongnikorn; Puttachart Maneesai; Narate Waisri; Chirapong Hanpragopsuk; Ekkasit Tharavichitkul; Isabelle Soerjomataram
Journal:  Cancer Epidemiol       Date:  2019-09-17       Impact factor: 2.984

3.  Effect of the national screening program on malignancy status of cervical cancer in Northern Thailand.

Authors:  Shama Virani; Hutcha Sriplung; Surichai Bilheem; Patumrat Sripan; Puttachart Maneesai; Narate Waisri; Imjai Chitapanarux
Journal:  Int J Public Health       Date:  2018-01-23       Impact factor: 3.380

4.  Cancer in Costa Rica.

Authors:  R Sierra; D M Parkin; G M Leiva
Journal:  Cancer Res       Date:  1989-02-01       Impact factor: 12.701

5.  Organization and evolution of organized cervical cytology screening in Thailand.

Authors:  Thiravud Khuhaprema; Pattarawin Attasara; Petcharin Srivatanakul; Suleeporn Sangrajrang; Richard Muwonge; Catherine Sauvaget; Rengaswamy Sankaranarayanan
Journal:  Int J Gynaecol Obstet       Date:  2012-05-19       Impact factor: 3.561

Review 6.  Effective screening programmes for cervical cancer in low- and middle-income developing countries.

Authors:  R Sankaranarayanan; A M Budukh; R Rajkumar
Journal:  Bull World Health Organ       Date:  2001-11-01       Impact factor: 9.408

7.  Rural-urban trends and patterns in cervical cancer mortality, incidence, stage, and survival in the United States, 1950-2008.

Authors:  Gopal K Singh
Journal:  J Community Health       Date:  2012-02

8.  Has universal health insurance reduced socioeconomic inequalities in urban and rural health service use in Thailand?

Authors:  Vasoontara Yiengprugsawan; Gordon A Carmichael; Lynette L-Y Lim; Sam-Ang Seubsman; Adrian C Sleigh
Journal:  Health Place       Date:  2010-07-04       Impact factor: 4.078

9.  Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study.

Authors:  Rebecca Landy; Francesca Pesola; Alejandra Castañón; Peter Sasieni
Journal:  Br J Cancer       Date:  2016-09-15       Impact factor: 7.640

10.  Evaluation of screening programmes for gynaecological cancer.

Authors:  M Hakama; J Chamberlain; N E Day; A B Miller; P C Prorok
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

View more
  2 in total

1.  Acceptability of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening in a Cohort of Patients from Romania (Stage 2).

Authors:  Mihaela Grigore; Ingrid-Andrada Vasilache; Petru Cianga; Daniela Constantinescu; Odetta Duma; Roxana Daniela Matasariu; Ioana-Sadiye Scripcariu
Journal:  J Clin Med       Date:  2022-04-29       Impact factor: 4.964

2.  Geographical risk pattern and temporal trends in incidence of HPV-related cancers in northern Thailand: A population-based study.

Authors:  Patumrat Sripan; Donsuk Pongnikorn; Imjai Chitapanarux; Arunrat Tangmunkongvorakul; Karnchana Daoprasert; Linda Aurpibul; Narate Waisri; Puttachart Maneesai; Galyarath Wannavongs; Voravit Suwanvanichkij; Kriengkrai Srithanaviboonchai
Journal:  PLoS One       Date:  2022-06-28       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.